Granules India Overview
- Year Founded
-
1984
- Status
-
Public
- Employees
-
4,306
- Stock Symbol
-
532482
- Investments
-
6
- Share Price
-
$8.66
- (As of Friday Closing)
Granules India General Information
Description
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. It has one segment: pharmaceutical products, including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and the Rest of the World. The company generates a majority of its revenue from its business outside India.
Contact Information
Website
www.granulesindia.comCorporate Office
- 15th Floor, Granules Tower
- Botanical Garden Road, Kondapur
- Hyderabad, Telengana 500084
- India
Corporate Office
- 15th Floor, Granules Tower
- Botanical Garden Road, Kondapur
- Hyderabad, Telengana 500084
- India
Granules India Stock Performance
As of 13-Nov-2026, Granules India’s stock price is $8.66. Its current market cap is $2.36B with 273M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $8.66 | $8.97 | $5.71 - $9.62 | $2.36B | 273M | 59.7K | $0.31 |
Granules India Financials Summary
As of 30-Sep-2026, Granules India has a trailing 12-month revenue of $630M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 2,466,679 | 1,748,551 | 1,481,168 | 1,377,831 |
| Revenue | 629,715 | 604,198 | 526,977 | 542,383 |
| EBITDA | 147,832 | 129,636 | 111,474 | 99,476 |
| Net Income | 76,961 | 67,338 | 59,311 | 48,959 |
| Total Assets | 923,639 | 818,202 | 730,958 | 662,040 |
| Total Debt | 114,586 | 160,254 | 170,069 | 157,694 |
Granules India Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Granules India Comparisons
Industry
Financing
Details
Granules India Competitors (13)
One of Granules India’s 13 competitors is Neuland Laboratories, a Corporation company based in Hyderabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neuland Laboratories | Corporation | Hyderabad, India | ||||
| Aarti Drugs | Corporation | Mumbai, India | ||||
| Natco Pharma | Corporation | Hyderabad, India | ||||
| Emcure Pharmaceuticals | Formerly PE-Backed | Pune, India | ||||
| Aurobindo Pharma | Corporation | Hyderabad, India |
Granules India Patents
Granules India Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026146392-A1 | Gamma-hydroxybutyric acid formulations | Pending | 31-Dec-2024 | ||
| WO-2026104966-A1 | Novel process for the preparation of elacestrant and its intermediates thereof | Pending | 13-Nov-2024 | ||
| US-20260041642-A1 | Sustained release pharmaceutical composition comprising potassium chloride | Pending | 07-Aug-2024 | ||
| WO-2026022682-A1 | An amorphous solid dispersion of elacestrant dihydrochloride and process for the preparation thereof | Pending | 24-Jul-2024 | ||
| WO-2026022646-A1 | Modified release pharmaceutical composition comprising gamma-hydroxybutyrate | Pending | 22-Jul-2024 | A61K31/19 |
Granules India Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Granules India Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Granules India Investments & Acquisitions (6)
Granules India’s most recent deal was a Merger/Acquisition with Granules Pharmaceuticals (Other Commercial Products) for . The deal was made on 20-Nov-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Granules Pharmaceuticals (Other Commercial Products) | 20-Nov-2025 | Merger/Acquisition | Other Commercial Products | ||
| Senn Chemicals | 10-Apr-2025 | Merger/Acquisition | Multi-line Chemicals | ||
| USPharma | 14-Jul-2016 | Secondary Transaction - Private | Drug Discovery | ||
| Granules-OmniChem | 20-Feb-2015 | Joint Venture | Other Pharmaceuticals and Biotechnology | ||
| Auctus Pharma | 14-Feb-2014 | Merger/Acquisition | Pharmaceuticals |
Granules India ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
32.55 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Granules India Exits (2)
Granules India’s most recent exit was on 20-Feb-2015 from Granules-OmniChem. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Granules-OmniChem | 20-Feb-2015 | Completed |
|
||
| Granules Biocause Pharmaceuticals | 06-Mar-2007 | Joint Venture | Completed |
|
Granules India Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Granules Pharmaceuticals | Chantilly, VA | 2014 | |
| Senn Chemicals | Zürich, Switzerland | 1963 |
Granules India FAQs
-
When was Granules India founded?
Granules India was founded in 1984.
-
Where is Granules India headquartered?
Granules India is headquartered in Hyderabad, India.
-
What is the size of Granules India?
Granules India has 4,306 total employees.
-
What industry is Granules India in?
Granules India’s primary industry is Pharmaceuticals.
-
Is Granules India a private or public company?
Granules India is a Public company.
-
What is Granules India’s stock symbol?
The ticker symbol for Granules India is 532482.
-
What is the current stock price of Granules India?
As of 13-Nov-2026 the stock price of Granules India is $8.66.
-
What is the current market cap of Granules India?
The current market capitalization of Granules India is $2.36B.
-
What is Granules India’s current revenue?
The trailing twelve month revenue for Granules India is $630M.
-
Who are Granules India’s competitors?
Neuland Laboratories, Aarti Drugs, Natco Pharma, Emcure Pharmaceuticals, and Aurobindo Pharma are some of the 13 competitors of Granules India.
-
What is Granules India’s annual earnings per share (EPS)?
Granules India’s EPS for 12 months was $0.31.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
